#sepsisdiagnostics

[industryexperts]

(via Blood Culture Test Market | Trends & Forecast 2025-2032)

The Blood Culture Test Market is set for strong growth through 2032 driven by rising sepsis cases, demand for rapid pathogen detection, and advances in automated and molecular diagnostic technologies. Explore trends, regional insights, and profiles of key global players in this comprehensive market report.

[medi-techinsights]

Global Sepsis Diagnostics Market valued at $510 million (2021), is set to witness a healthy growth of 9% in upcoming 5 years

Sepsis is a life-threatening medical emergency. It is body's reaction to infection that may lead to a systemic inflammatory reaction, tissue damage, and ultimately organ dysfunction and/or failure.

As per WHO, globally, sepsis affects around 49 million people each year. Early diagnosis of sepsis is critical for patient outcomes. However, diagnosing sepsis is not an easy task as there is no particular symptom or sign that are directly related to the disease.

Development of Rapid Diagnostic Tests/Point-of-Care Techniques

Currently, clinicians possess limited technology needed to conduct multiplexed and fully quantitative diagnostic tests at the point of care with high sensitivity. Citing the need for rapid diagnostic tests, several research universities and product manufacturers are developing innovative rapid diagnostic tests/point-of-care techniques.

For instance,

· Researchers at the University of Strathclyde have developed an innovative, low cost test for early diagnosis of sepsis. The experimental device analyzes patient's blood and provides results in just 2.5 minutes compared to current testing methods for sepsis which takes up to 72 hours.

Development of rapid diagnostic tests/point-of-care techniques, growing cases of sepsis & hospital-acquired infections, and favorable initiatives & funding for sepsis-related research are the key factors driving the growth of the Global Sepsis Diagnostics Market.

Get Customized Report on Sepsis Diagnostics Market @ https://meditechinsights.com/sepsis-diagnostics-market/

Favorable Initiatives & Funding for Sepsis Research

In an endeavor to shape the future of sepsis research, (NIGMS) intends to use the NIH SBIR/STTR program to support preclinical and clinical sepsis studies to develop improved diagnostic tools and therapies.

Diagnostics companies are also continuously securing funding to develop rapid sepsis diagnostic tests.

For instance,

· In February 2022, CytoVal, a medical diagnostics company secured additional funding from Biomedical Advanced Research and Development Authority (BARDA) to help advance the company’s 10-minute IntelliSep™ sepsis risk stratification test towards commercial launch

· In June 2021, HelixBind secured $3 million National Institutes of Health (NIH) grant to support testing of its rapid diagnostic platform for invasive infections associated with sepsis

Competitive Landscape Analysis: Sepsis Diagnostics Market

The Sepsis Diagnostics market is marked by presence of both established players such as bioMérieux, Becton, Dickinson and Company, Thermo Fisher Scientific, Danaher Corporation and innovative firms such as Seegene Inc., Axis-Shield Diagnostics, Immunexpress, and others.

For Detailed Insights on Sepsis Diagnostics Market, Contact Us @ https://meditechinsights.com/contact-us/